Agenda
1:30 PM — 2:30 PM
Is Your App a Drug, a Device, or Something Else Entirely?3:30 PM — 4:30 PM
FDA’s Considerations on Benefit-Risk Assessment for Human Drug Review9:30 AM — 10:30 AM
ACTIV: A Public-Private Partnership to Speed COVID-19 Therapies and Vaccines11:30 AM — 12:30 PM
Accelerated Approval and Emerging Surrogate Endpoints2:00 PM — 3:00 PM
Utilizing Cloud-Based Platforms in Regulatory Contexts8:00 AM — 9:00 AM
ICH 30th Anniversary: Achievements and Future Prospects2:00 PM — 3:00 PM
Best Practices for Virtual Meetings with FDA!8:00 AM — 9:00 AM
FDA-PAHO: Landscape Report of Regulatory Situation in the Americas5:00 PM — 6:00 PM
ON DEMAND - New Drugs Regulatory Program Modernization5:00 PM — 6:00 PM
ON DEMAND - Regulatory Barriers to Entry for Biosimilars5:00 PM — 6:00 PM
ON DEMAND - Updates of Drug Evaluation and Inspection in ChinaHave an account?